| Product Code: ETC8836905 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pharmaceutical cannabis market focuses on developing prescription-grade formulations for various medical conditions. Partnerships between local and global players are expected to drive research, innovation, and market growth.
The Cannabis Pharmaceutical Market in the Philippines focuses on prescription cannabis products, including oils, capsules, sprays, and other formulations standardized for medical use. Growth in this market depends on government approvals, investment in research and development, and the establishment of clinical protocols. If medical cannabis is legalized, the pharmaceutical segment is poised to become one of the most regulated yet promising sectors.
The cannabis pharmaceutical market in the Philippines faces challenges due to the country`s restrictive legal environment around cannabis. While there is potential for medical cannabis to be used as a treatment for various conditions, the absence of a clear regulatory framework limits the development and availability of cannabis-based pharmaceutical products. Furthermore, the lack of trained medical professionals and insufficient public awareness about the potential benefits of cannabis-based medicine make it difficult for this market to grow. High production and regulatory compliance costs also represent significant barriers.
The cannabis pharmaceutical market in the Philippines is expected to grow as the acceptance of cannabis-based therapies expands. With increasing evidence supporting the medicinal benefits of cannabis, the demand for pharmaceutical-grade products is on the rise. Investors can explore opportunities in cannabis research and the development of pharmaceutical products aimed at treating various medical conditions, positioning themselves in a promising and expanding sector.
Cannabis pharmaceuticals are under the same restrictions as other cannabis products. The FDA, DOH, and PDEA would be the primary regulators if any medical cannabis formulations are approved, setting strict guidelines on clinical trials, manufacturing, distribution, and patient access.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Cannabis Pharmaceutical Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Philippines Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Philippines Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in the Philippines |
4.2.2 Growing awareness about the potential benefits of cannabis-based pharmaceutical products |
4.2.3 Favorable government regulations and policies supporting the use of cannabis for medical purposes |
4.3 Market Restraints |
4.3.1 Limited availability of high-quality cannabis strains for pharmaceutical use |
4.3.2 Concerns regarding the abuse potential and regulatory challenges associated with cannabis products |
5 Philippines Cannabis Pharmaceutical Market Trends |
6 Philippines Cannabis Pharmaceutical Market, By Types |
6.1 Philippines Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Philippines Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Philippines Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Philippines Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Philippines Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Philippines Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Philippines Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Philippines Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Philippines Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Philippines Cannabis Pharmaceutical Market Imports from Major Countries |
8 Philippines Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis-based pharmaceutical products in the Philippines |
8.2 Patient satisfaction and reported health outcomes from using cannabis pharmaceuticals |
8.3 Investment in research and development of new cannabis-based pharmaceutical products in the Philippines |
9 Philippines Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Philippines Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Philippines Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Philippines Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |